Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

about

Pharmacokinetics of the protein microbicide 5P12-RANTES in sheep following single dose vaginal gel administration.Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.

P2860

Q38636239-9A9F7E94-413E-4240-B0A4-AD4B9B89E285 Q46503602-29507F16-DE2E-4A63-A5FF-96DF53031AFD

P2860

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

Item

http://www.wikidata.org/entity/Q36918627

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

@en

type

Item

label

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

@en

prefLabel

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

@en

P1476

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

@en

P2093

Annalene Nel

http://www.w3.org/2001/XMLSchema#string

Bríd Devlin

http://www.w3.org/2001/XMLSchema#string

Neliëtte van Niekerk

http://www.w3.org/2001/XMLSchema#string

Patrick Spence

http://www.w3.org/2001/XMLSchema#string

Susan Wilder

http://www.w3.org/2001/XMLSchema#string

Tiffany Derrick

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy

A cross cultural study of vaginal practices and sexuality: implications for sexual health.

Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.

A vaginal fluid simulant.

Design of an intravaginal ring for the controlled delivery of 17 beta-estradiol as its 3-acetate ester.

An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings

Microbicide clinical trial adherence: insights for introduction

Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use.

A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.

P304

94-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPBA.2016.03.023

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27016673

http://www.w3.org/2001/XMLSchema#string

P932

4873601

http://www.w3.org/2001/XMLSchema#string

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

about

P2860

P2860

Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932